Real-World Effectiveness and Prognostic Factors Analysis of Stages I–III Non-Small Cell Lung Cancer Following Neoadjuvant Chemo-Immunotherapy or Neoadjuvant Chemotherapy

Purpose: Immune checkpoint inhibitors (ICIs) have been successfully used in many clinical trials related to immunotherapy. This study aimed to investigate the clinical efficacy of ICIs and prognostic factors in patients with resectable non-small cell lung cancer (NSCLC) following neoadjuvant therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zuo, Gao, Zhaoming, Zhang, Mengzhe, Wang, Xiaofei, Gong, Jialin, Jiang, Shuai, Zhang, Zhenfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081467/
https://www.ncbi.nlm.nih.gov/pubmed/34776459
http://dx.doi.org/10.5761/atcs.oa.21-00143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081467/
https://www.ncbi.nlm.nih.gov/pubmed/34776459
http://dx.doi.org/10.5761/atcs.oa.21-00143

Ejemplares similares